Eli Lilly Downgraded To Neutral From Outperform At Credit Suisse
October 10, 2017 at 10:21 AM EDT
Credit Suisse analyst Vamil Divan downgraded Eli Lilly to Neutral saying the valuation looks full with the shares up 13% since mid-August. The analyst sees limited drivers for further upside.
